NCT04440189View on ClinicalTrials.gov

Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

December 30, 2024

Study Completion Date

June 30, 2025

Conditions
Osteoarthritis, Knee
Interventions
DEVICE

GID SVF-2 Device System

The GID SVF-2 Device System is used for harvesting, filtering, separating and concentrating autologous stromal vascular fraction from adipose tissue.

Trial Locations (9)

15261

University of Pittsburgh Medical Center, Pittsburgh

27106

Wake Forest University Health Sciences, Winston-Salem

28207

OrthoCarolina Research Institute, Charlotte

33067

Advanced Research LLC, Coral Springs

43202

Ohio State University Jameson Crane Sports Medicine Institute, Columbus

70112

Tulane University, New Orleans

78240

Texas Center for Cell Therapy and Research, San Antonio

95817

UC Davis, Sacramento

07927

New Jersey Regenerative Institute, Cedar Knolls

All Listed Sponsors
lead

GID BIO, Inc.

INDUSTRY

NCT04440189 - Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis | Biotech Hunter | Biotech Hunter